LoginSubscribe DatabaseScreen Shots


PharmEng Announces Corporate Restructuring

TechFinance.ca News
Monday April 13, 2009

PharmEng International Inc. (TSX-V: PII) announced as part of its ongoing efforts to restructure the company and re...



[ ... to read the whole article, subscription is required ... ]



... ... ctors.


To read this or any other article, or trial test our database, please try our 7 days or 1 month subscription, Click Here for Details.





Company Deals and People
Date
Title
Type
2008/4/9
John Durham, Corporate VP, Business Development, Keata Pharma Inc.
Management
2007/8/17
Shropshire Acquires Additional PharmEng Shares Through Warrant Exercise
Financing
2007/7/9
Edgar (Ed) Parker, Chairman
Director
2007/5/18
PharmEng Acquires Control of Beijing BRD Lixin PharmaTech
M&A
2007/5/14
PharmEng International Closes Brokered Private Placement
Financing
2007/4/24
PharmEng International Completes Private Placement
Financing
2007/4/2
PharmEng International Closes Private Placement
Financing
2006/10/30
Clarence H. (Bert) Loveless, CFO
Management
2006/8/8
PharmEng International Completes Private Placement
Financing
2006/8/8
PharmEng International Closes Loan Financing
Financing
2006/5/1
PharmEng International Closes Acquisition of Rootlink Technic
M&A
2005/8/24
PharmEng International Completes Final Tranche of Private Placement
Financing
2005/8/4
PharmEng International Closes Private Placement
Financing
2005/4/27
PharmEng Technology Goes Public on TSX Venture Exchange
RTO, QT
2005/2/22
PharmEng Technology Completes Financing
Financing
2004/12/14
PharmEng Technology Closes Financing
Financing

 
PharmEng International Inc.
TSX-V: PII
formerly: PharmEng Technology Inc.
» To this firm page « (subscriber only)
47-145 Royal Crest Court
Markham, ON   L3R 9Z4
Tel:  (905) 229-9333
Fax:  (905) 415-3966
http://www.pharmeng.com
Sector - Biopharma Services
Business Description
PharmEng is a full service consulting and manufacturing company serving the pharmaceutical and allied industries. Its service includes project management, engineering, cGMP and validation, product development, calibration services, training and regulatory compliance.


Company News
A. Farber & Partners Appointed Interim Receiver for the Sales Assets of PharmEng 2009/5/15
PharmEng Announces Reclassification to Tier 2 and Suspension Notice 2009/4/21
PharmEng Announces Further Resignation 2009/4/13
PharmEng Announces Corporate Restructuring 2009/4/13